secwatch.observer — SEC 8-K summary
======================================

Issuer:     Comera Life Sciences Holdings, Inc. (—)
CIK:        0001907685
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0000950170-23-064530
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Comera Life Sciences receives Nasdaq delisting notice; no appeal; securities to move to OTC Markets
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel determined to delist common stock (CMRA) and warrants (CMRAW) effective Nov 17, 2023.
- Company will not appeal; expects Form 25-NSE to be filed with SEC.
- Failure to regain compliance with MVLS ($35M minimum) and minimum bid price ($1.00) by Nov 14, 2023.
- Common stock and warrants expected to trade on OTC Markets under same symbols starting Nov 17; applied for OTCQB.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907685/000095017023064530/0000950170-23-064530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907685/000095017023064530/cmra-20231115.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-064530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer